Results 101 to 110 of about 827 (180)

Carbapenem Resistance in Acinetobacter baumannii: Mechanisms, Therapeutics, and Innovations

open access: yesMicroorganisms
The global rise of carbapenem-resistant Acinetobacter baumannii (CRAB) strains poses a critical challenge to healthcare systems due to limited therapeutic options and high mortality rates, especially in intensive care settings.
Joyce de Souza   +5 more
doaj   +1 more source

β-Lactam/β-Lactamase Inhibitor Combinations in Sepsis-Associated Acute Kidney Injury and Renal Replacement Therapy

open access: yesAntibiotics
Sepsis-associated acute kidney injury (SA-AKI) often requires renal replacement therapy (RRT), which markedly alters antimicrobial pharmacokinetics (PK) and pharmacodynamics (PD). Novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations broaden options
Antonio Lacquaniti   +10 more
doaj   +1 more source

Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence

open access: yesAntibiotics
It is estimated that antimicrobial resistance (AMR) is responsible for nearly 5 million human deaths worldwide each year and will reach 10 million by 2050.
Francesca Serapide   +8 more
doaj   +1 more source

Friends or foes? Novel antimicrobials tackling MDR/XDR Gram-negative bacteria: a systematic review

open access: yesFrontiers in Microbiology
Gram-negative bacteria have been one of the most studied classes in the field of microbiology, especially in the context of globally alarming antimicrobial resistance levels to these pathogens over the course of the past decades.
Mihai Octavian Dan   +2 more
doaj   +1 more source

Nephrotoxicity of New Antibiotics: A Systematic Review

open access: yesToxics
Drug-induced nephrotoxicity is a common and serious problem in clinical practice. We conducted a systematic review of studies reporting nephrotoxicity events associated with antibiotics approved since 2018.
Panagiotis Stathopoulos   +3 more
doaj   +1 more source

Opciones terapéuticas para infecciones por gérmenes ESKAPE en países de bajos recursos. Revisión sistemática [PDF]

open access: yes
Introducción: El término ESKAPE, acuñado hace más de una década, designa a un grupo de bacterias que tienen la habilidad de “escapar” a la acción de los antibióticos.
Castro Reyes, Evelyn Elizabeth   +1 more
core   +1 more source

Current Advances in Developing New Antimicrobial Agents Against Non-Tuberculous Mycobacterium

open access: yesAntibiotics
Non-tuberculous mycobacteria (NTM) comprise more than 190 species capable of causing severe pulmonary, lymphatic, cutaneous, and disseminated infections, particularly in immunocompromised populations.
Jane Cross   +2 more
doaj   +1 more source

Novel Insights into Carbapenem Resistance: Mechanisms, Diagnostics, and Future Directions

open access: yesAntibiotics
Carbapenems are essential for the treatment of severe infections caused by Gram-negative bacteria, particularly in critically ill and immunocompromised patients.
Ionela-Larisa Miftode   +9 more
doaj   +1 more source

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study [PDF]

open access: yes
[Abstract]: Background: As increasing antibiotic resistance in Acinetobacter baumannii poses a global healthcare challenge, understanding its evolution is crucial for effective control strategies.
Alonso-Garcia, Isaac   +11 more
core   +2 more sources

Global trends in carbapenem-resistant gram-negative bacteria research (2020–2025): a bibliometric analysis and systematic review

open access: yesFrontiers in Cellular and Infection Microbiology
BackgroundCarbapenem-resistant Gram-negative bacteria (CRGNB) pose a severe global health threat, yet comprehensive bibliometric analyses in this field remain limited.
Xiaotong Zhang   +29 more
doaj   +1 more source

Home - About - Disclaimer - Privacy